Dilon inks sales pact with PenRad

Breast-specific gamma imaging developer Dilon Diagnostics has signed a three-year sales agreement with mammography information systems developer PenRad Technologies.

Under the terms of the pact, Dilon's portfolio now will include the PenRad mammography information system (MIS) and also Volpara, a quantitative breast density assessment tool designed to convert a qualitative breast x-ray image into quantitative data.